Aptose Biosciences Inc (NAS:APTO)
$ 0.3737 0.0123 (3.4%) Market Cap: 6.62 Mil Enterprise Value: -1.11 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 29/100

Q3 2020 Aptose Biosciences Inc Earnings Call Transcript

Nov 10, 2020 / 10:00PM GMT
Release Date Price: $67.95 (+0.44%)
Operator

Good afternoon. My name is Chris, and I'll be your conference operator today. I would like to welcome everyone to Aptose Biosciences' Conference Call for the Third Quarter Ended September 30, 2020. (Operator Instructions) And as a reminder, this conference call may be recorded.

I would now like to introduce Ms. Susan Pietropaolo. Please go ahead.

Susan M. Pietropaolo;William G. Rice
SMP Communications, Inc. - Principal;Aptose Biosciences

Thank you, Chris. Good afternoon, and welcome to the Aptose Biosciences conference call to discuss financial and operational results for the third quarter ended September 30, 2020. I am Susan Pietropaolo, a communications representative for Aptose Biosciences.

Joining me on the call today are Dr. William G. Rice, Chairman, President and CEO; Mr. Gregory Chow, Executive Vice President and Chief Financial Officer; Dr. Jotin Marango, Senior Vice President and Chief Business Officer; Dr. Rafael Bejar, Senior Vice President and Chief Medical Officer.

Do you all hear that?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot